Studies induction anterior chamber-associated immune deviation ACAID Evidence antigen-specific ACAID-inducing cell-associated signal exists peripheral blood anterior chamber eye privileged site Recent evidence privilege immune state unique form systemic immune deviation exists anterior chamber-associated immune deviation ACAID ACAID part generation Ag-specific splenic mediate suppression induction expression delayed hypersensitivity suppress production C-fixing antibodies Delayed hypersensitivity fixation extensive nonspecific inflammation innocent bystander tissue injury ACAID physiologic adaptations immune system wanton destruction delicate visual axis sight time selective immune protection means potential contribution eye ACAID induction immune properties blood mice BSA anterior chamber Ag-specific signal present blood mice blood naive syngeneic mice regulatory cell populations recipients unable BSA-specific delayed hypersensitivity Further analysis signal leukocyte fraction plasma RBC components whole blood leukocytes suppression-inducing activity cells mature macrophage marker cells surface Ig class II MHC molecules findings regard potential intraocular sources ACAID-inducing signal possible mode action factor 